¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"passive cutaneous anaphylaxis test2"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cutaneous habronemiasis
    ÇǺÎÇϺê·Î³×¸¶Áõ
  • cutaneous hallucination
    ÇǺÎȯ°¢
  • cutaneous helminthiasis
    ÇǺο¬ÃæÁõ
  • cutaneous horn
    ÇǺλÔ
  • cutaneous larva migrans
    ÇǺξֹú·¹ÀÌÇàÁõ, ÇǺÎÀ¯ÃæÀÌÇàÁõ
  • cutaneous leishmaniasis
    ÇǺθ®½´¸¸Æí¸ðÃæÁõ
  • cutaneous lymphoid hyperplasia
    ÇǺθ²ÇÁ°ú´ÙÇü¼º
  • cutaneous mucosal hyalinosis
    ÇǺÎÁ¡¸·À¯¸®ÁúÁõ
  • cutaneous necrotizing venulitis
    ÇǺα«»ç¼¼Á¤¸Æ¿°
  • cutaneous neoplasm
    ÇǺÎÁ¾¾ç
  • cutaneous nerve
    ÇǺνŰæ
  • cutaneous nerve ending
    ÇǺνŰæÁ¾¸»
  • cutaneous nerve somatosensory evoked potential
    ÇǺνŰæ¸ö°¨°¢À¯¹ßÀüÀ§
  • cutaneous reaction
    ÇǺιÝÀÀ
  • cutaneous ridge
    ÇǺδɼ±
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cutaneous larva migrans
    ÇǺξֹú·¹ÀÌÇàÁõ, ÇǺÎÀ¯ÃæÀÌÇàÁõ
  • cutaneous disorder
    ÇǺÎÁúȯ
  • cutaneous endometriosis
    Ç¥ÀçÀڱ󻸷Áõ, Ç¥¸éÀڱ󻸷Áõ
  • cutaneous gangrene
    ÇǺα«Àú
  • cutaneous habronemiasis
    ÇǺÎÇϺê·Î³×¸¶Áõ
  • cutaneous hallucination
    ÇǺÎȯ°¢
  • cutaneous helminthiasis
    ÇǺο¬ÃæÁõ
  • cutaneous horn
    ÇǺλÔ
  • cutaneous leishmaniasis
    ÇǺθ®½´¸¸Æí¸ðÃæÁõ
  • cutaneous neoplasm
    ÇǺÎÁ¾¾ç
  • cutaneous nerve
    ÇǺνŰæ
  • cutaneous reaction
    ÇǺιÝÀÀ
  • cutaneous ridge
    ÇǺδɼ±
  • cutaneous sarcoidosis
    ÇǺλ縣ÄÚÀ̵åÁõ
  • cutaneous schistosomiasis
    ÇǺÎÁÖÇ÷ÈíÃæÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • anterior cutaneous branch (of thorax)
    ¾Õ(°¡½¿)ÇǺΰ¡Áö
  • anterior cutaneous branches
    ¾ÕÇǺΰ¡Áö
  • graft, perichondral cutaneous
    ¿¬°ñ¸·ÇǺÎÀ̽Ä
  • hallucination, cutaneous
    ÇǺÎȯ°¢(ù«Ý±ü³ÊÆ)
  • inferior lateral cutaneous nerve of arm
    ¾Æ·¡°¡ÂÊÀ§ÆÈÇǺνŰæ
  • posterior cutaneous branch
    µÚÇǺΰ¡Áö
  • posterior cutaneous nerve of arm
    µÚÀ§ÆÈÇǺνŰæ
  • posterior cutaneous nerve of forearm
    µÚ¾Æ·¡ÆÈÇǺνŰæ
  • posterior femoral cutaneous nerve
    µÚ³Ò´Ù¸®ÇǺνŰæ
  • primary cutaneous adenocystic carcinoma
    ¿ø¹ß¼º ÇǺΠ¼±³¶Á¾¼º¾Ï
  • primary localized cutaneous amyloidosis
    ¿ø¹ß¼º ±¹¼Ò ÇǺΠÀ¯ÀüºÐÁõ
  • random cutaneous flap
    ÀÓÀÇÇÇÆÇ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • respiratory anaphylaxis
    È£Èí¼º ¾Æ³ªÇʶô½Ã.
  • respiratory anaphylaxis
    È£Èí¼º ¾Æ³ªÇʶô½Ã½º.
  • reverse anaphylaxis
    ¿ª¾Æ³ªÇʶô½Ã(潡­)
  • reversed anaphylaxis
    ¿ª¾Æ³ªÇʶô½Ã½º.
  • slow reacting substance of anaphylaxis
    ¾Æ³ªÇʶô½Ã½º Áö¿¬¹ÝÀÀ¹°Áú
  • agglutination, passive
    ¼öµ¿ÀÀÁý
  • appreciation of passive movement
    ¼öµ¿¿îµ¿°¨°¢.
  • congestion,chronic passive
    ¸¸¼º Çǵ¿¼º(Ø·àõù¬ÔÑàõ)
  • downhill transport =passive t.
    Çǵ¿¿î¹Ý(ù¬ÔÑê¡Úæ).
  • hemagglutination, passive
    ¼öµ¿ Ç÷±¸ÀÀÁý
  • hemagglutination, reversed passive
    ¿ª¼öµ¿ Ç÷±¸ÀÀÁý¹ÝÀÀ
  • immunity, passive
    ¼öµ¿¸é¿ª
  • immunization, passive
    ¼öµ¿¸é¿ª
  • indirect passive agglutination
    °£Á¢¼öµ¿ÀÀÁý(¹ÝÀÀ).
  • passive agglutination
    ¼öµ¿ÀÀÁý
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Cutaneous part
    ÇǺκκÐ
    [¿¾ ¿ë¾î] ÇǺκÎ
  • Cutaneous region
    ÇǺκÎÀ§
    [¿¾ ¿ë¾î] ÇǺκÎ
  • Cutaneous gland
    ÇǺλù
    [¿¾ ¿ë¾î] ÇǺμ±
  • Cutaneous nerve terminal
    ÇǺνŰæÁ¾¸» (¢Ñ ½Å°æÁ¾¸»)
    [¿¾ ¿ë¾î] ÇǺνŰæÁ¾¸»
  • Cutaneous vein
    ÇǺÎÁ¤¸Æ
    [¿¾ ¿ë¾î] ÇÇÁ¤¸Æ
  • Cutaneous layer
    ÇǺÎÃþ
    [¿¾ ¿ë¾î] ÇǺÎÃþ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CPC central posterior curve; cerebellar Purkinje cell; cerebral palsy clinic; cerebral performance categ...
CPM central pontine myelinosis; chlorpheniramine maleate; continuous passive motion; critical path metho...
FPM filter paper microscopic [test]; full passive movements
PA panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'...
PAP pancreatitis-associated protein; Papanicolaou [test]; papaverine; passive-aggressive personality; pa...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PAR Passive Anterior Rhinomanometry
PAR Passive Avoidance Response
PHA Passive Haemagglutination
PHN Passive Heymann nephritis
PHA Passive hemagglutination assays
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cutaneous metastatic carcinoma
    ÇǺΠÀüÀÌ ¾Ï, ÇǺΠÀüÀÌ ¾ÏÁ¾
  • cutaneous myxoid cyst
    ÇǺΠÁ¡¾×¾ç ³¶Á¾
  • cutaneous nerve
    ÇǺΠ½Å°æ, ÇÇ ½Å°æ
  • cutaneous nociceptor
    ÇÇºÎ Ä§ÇØ ¼ö¿ëü, ÇǺΠÀ¯ÇØ ¼ö¿ë±â
  • cutaneous part
    ÇǺΠÆí
  • cutaneous polymodal nociceptor
    ÇǺΠ´ÙÇü Ä§ÇØ ¼ö¿ëü, ÇǺΠ´ÙÇü À¯ÇØ ¼ö¿ë±â
  • cutaneous pseudolymphoma
    ÇǺΠ°¡¼º ¸²ÇÁÁ¾
  • cutaneous reaction
    ÇǺΠ¹ÝÀÀ
  • cutaneous region
    ÇǺΠºÎÀ§
  • cutaneous spot
    ÇǺΠ¹Ý, ÇǺΠ¹ÝÁ¡
  • cutaneous symptom
    ÇǺΠÁõ»ó
  • cutaneous trigger point
    ÇǺΠ¹ßÅëÁ¡
  • cutaneous vein
    ÇǺΠÁ¤¸Æ, ÇÇÁ¤¸Æ
  • familial cutaneous collagenosis
    °¡Á·¼º ÇǺΠ±³¿øÁõ
  • laryngo-onycho-cutaneous syndrome
    ÈĵÎ-¼Õ ¹ßÅé-ÇǺΠÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
passive haemagglutination A kind of passive agglutination in which erythrocytes, usually modified by mild treatment with tannic acid or other chemicals, are used to adsorb soluble antigen onto their surface, and which then agglutinate in the presence of antiserum specific for the adsorbed antigen.
Synonym: indirect haemagglutination test.
(05 Mar 2000)
passive hyperaemia Hyperaemia due to an obstruction in the flow of blood from the affected part, the venous radicles becoming distended.
Synonym: venous hyperaemia.
(05 Mar 2000)
passive immunity <immunology> Immunity acquired by the transfer from another animal of antibody or sensitised lymphocytes. Passive transfer of antibody from mother to offspring is important for immune defense during the perinatal period.
(18 Nov 1997)
passive immunization The production of passive immunity.
(05 Mar 2000)
passive immunotherapy <immunology> A process in which individuals with advanced disease (who have low levels of HIV antibody production) are infused with plasma rich in HIV antibodies or an immunoglobulin concentrate (HIV Ig) from such plasma. The plasma is obtained from asymptomatic HIV-positive individuals with high levels of HIV antibodies.
(09 Oct 1997)
passive incontinence Dribbling of urine by reason of inability of the bladder to empty itself and of consequent overdistention.
See: overflow incontinence.
(05 Mar 2000)
passive learning Learning without a direct attempt.
Synonym: passive learning.
(05 Mar 2000)
passive length-tension curve The relationship between passive tension and preload (rest length) for a muscle at rest.
(05 Mar 2000)
passive medium A medium that produces no change in the specimens placed in it.
(05 Mar 2000)
passive movement Movement imparted to an organism or any of its parts by external agency; movement of any joint effected by the hand of another person, or by mechanical means, without participation of the subject himself.
(05 Mar 2000)
passive prophylaxis Use of an antiserum from another person or animal to provide temporary (a week to 10 days) protection against a specific infectious or toxic agent.
(05 Mar 2000)
passive transference The passage of an immunity or allergic susceptibility by the injection of serum of an animal or individual who has acquired an active immunity to the disease.
(05 Mar 2000)
passive transport <biochemistry, physiology> The movement of a substance, usually across a plasma membrane, by a mechanism that does not require metabolic energy.
See: active transport, transport protein, facilitated diffusion, ion channels.
(18 Nov 1997)
passive tremor A coarse, rhythmic tremor, 3-5 Hz frequency, usually confined to hands and forearms, that appears when the limbs are relaxed, and disappears with active limb movements; characteristic of Parkinson disease.
Synonym: passive tremor.
(05 Mar 2000)
passive vasoconstriction Reduced caliber of a vessel caused by decreased intraluminal pressure.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á